RVNC stock

This Healthcare Analyst Pounds the Table on Revance Therapeutics Inc (RVNC)

Guggenheim’s Rohit Vanjani puts a price tag on Revance Therapeutics.

Jason Cohen — December 5, 2017, 7:13 PM EDT